基于非线性混合模型的时间-活度信息共享方法:减少成像时间点的患者特异性剂量学在177Lu-DOTATATE治疗后SPECT/CT中的应用
本研究提出一种基于统计混合模型、利用历史队列完整时间-活度数据和新增患者仅1或2个成像点进行肾脏时间-活度联合估计的新方法,并与既往单时间点方法在虚拟和临床患者数据中比较。结果显示混合模型在虚拟队列中平均偏差小于7%,偏差更低、精度更高、离群值更少;临床患者中1点和2点混合模型分别对94%(17/18)和72%(13/18)的肾脏获得更准确的TIA估计。结论认为混合模型可在保持准确性的同时减少成像负担。
要点
- 混合模型利用历史完整数据联合估计新患者肾脏时间-活度,仅需1或2个SPECT/CT时间点。
- 虚拟队列中混合模型平均偏差小于7%,且偏差、精度和离群值均优于单时间点方法。
- 临床患者中1点和2点混合模型分别对94%和72%的肾脏获得更准确TIA估计。
核心结论
- 基于历史完整时间-活度数据和新患者仅1或2次SPECT/CT的混合模型,在估计肾脏TIA时平均偏差更小、离群值显著少于常用的减少时间点方法。
- 混合模型可在保持准确性的同时减少成像负担,对基于剂量学的治疗的临床实施至关重要。
研究设计与样本
- 研究纳入10例接受177Lu-DOTATATE治疗并在第0至7天最多成像4次的神经内分泌肿瘤患者,使用SPECT/CT获取时间-活度数据。
- 在临床队列中回顾性评估使用1或2个时间点的混合模型,以多时间点拟合为参考。
- 利用临床队列参数值生成250例虚拟患者的时间-活度数据,对每例虚拟患者使用1个(约96 h)和2个(4 h、约96 h)时间点并结合同数据集其他患者完整数据拟合混合模型。
主要发现
- 虚拟队列中所有混合模型和单时间点方法总体表现良好,平均偏差小于7%。
- 混合模型较单时间点方法偏差更低、精度更高、离群值显著更少。
- 临床患者中1点和2点混合模型分别对94%(17/18)和72%(13/18)的肾脏获得更准确的TIA估计。
- 虚拟患者中混合模型使|偏差|>10%的肾脏比例降低超过2倍(6% vs. 15%)。
临床怎么用
- 对于接受177Lu-DOTATATE治疗的患者,可利用历史完整时间-活度数据和新患者仅1或2次SPECT/CT扫描进行肾脏剂量学估计,减少成像负担。
- 混合模型在保持准确性的同时减少离群值,适合临床实施基于剂量学的治疗。
局限性
- 临床队列样本量较小(10例患者)。
- 研究为回顾性评估,虚拟患者数据基于临床队列参数生成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple-time-point SPECT/CT imaging for dosimetry is burdensome for patients and lacks statistical efficiency. A novel method for joint kidney time-activity estimation based on a statistical mixed model, a prior cohort of patients with complete time-activity data, and only 1 or 2 imaging points for new patients was compared with previously proposed single-time-point methods in virtual and clinical patient data. Methods: Data were available for 10 patients with neuroendocrine tumors treated with 177Lu-DOTATATE and imaged up to 4 times between days 0 and 7 using SPECT/CT. Mixed models using 1 or 2 time points were evaluated retrospectively in the clinical cohort, using the multiple-time-point fit as the reference. Time-activity data for 250 virtual patients were generated using parameter values from the clinical cohort. Mixed models were fit using 1 (∼96 h) and 2 (4 h, ∼96 h) time points for each virtual patient combined with complete data for the other patients in each dataset. Time-integrated activities (TIAs) calculated from mixed model fits and other reduced-time-point methods were compared with known values. Results: All mixed models and single-time-point methods performed well overall, achieving mean bias < 7% in the virtual cohort. Mixed models exhibited lower bias, greater precision, and substantially fewer outliers than did single-time-point methods. For clinical patients, 1- and 2-time-point mixed models resulted in more accurate TIA estimates for 94% (17/18) and 72% (13/18) of kidneys, respectively. In virtual patients, mixed models resulted in more than a 2-fold reduction in the proportion of kidneys with |bias| > 10% (6% vs. 15%). Conclusion: Mixed models based on a historical cohort of patients with complete time-activity data and new patients with only 1 or 2 SPECT/CT scans demonstrate less bias on average and significantly fewer outliers when estimating kidney TIA, compared with popular reduced-time-point methods. Use of mixed models allows for reduction of the imaging burden while maintaining accuracy, which is crucial for clinical implementation of dosimetry-based treatment.
引用
- Devasia TP, Dewaraja YK, Frey KA, et al. A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After 177Lu-DOTATATE. J Nucl Med. 2020. PMID: 33443063. doi:10.2967/jnumed.120.256255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。